BEAMS Trademark

Trademark Overview


On Tuesday, June 3, 2025, a trademark application was filed for BEAMS with the United States Patent and Trademark Office. The USPTO has given the BEAMS trademark a serial number of 79430371. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Thursday, January 15, 2026. This trademark is owned by BEAMS. The BEAMS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development services in the field of medical therapies, namely, basic, clinical and preclinical medical research, developing innovative therapeutic solutions in the nature of pharmaceutical preparations and medicines, and performing scientific feasibility studies aimed at diagnosing, preventing and treating pathologies in all medical fields; pharmacological, biological, microbiological, genetic, biotechnological and biomedical research services; designing and developing medical and scientific research, namely, conducting clinical and preclinical trials for others; scientific research in analyzing and interpreting biomedical data and health data; scientific laboratory analysis and therapeutic test services with a view to developing new treatments; advice on product research and development for precision and customized therapies; implementing of computer technologies for others for therapeutic simulation, molecular modeling and research in artificial intelligence applied to ...
beams

General Information


Serial Number79430371
Word MarkBEAMS
Filing DateTuesday, June 3, 2025
Status653 - SUSPENSION LETTER - MAILED
Status DateThursday, January 15, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesResearch and development services in the field of medical therapies, namely, basic, clinical and preclinical medical research, developing innovative therapeutic solutions in the nature of pharmaceutical preparations and medicines, and performing scientific feasibility studies aimed at diagnosing, preventing and treating pathologies in all medical fields; pharmacological, biological, microbiological, genetic, biotechnological and biomedical research services; designing and developing medical and scientific research, namely, conducting clinical and preclinical trials for others; scientific research in analyzing and interpreting biomedical data and health data; scientific laboratory analysis and therapeutic test services with a view to developing new treatments; advice on product research and development for precision and customized therapies; implementing of computer technologies for others for therapeutic simulation, molecular modeling and research in artificial intelligence applied to life sciences; consultation with respect to medical research; scientific research; technical scientific and medical research; software design in the therapeutic field; software development in the field of medical devices; research and development of new products for third parties; quality control for others; laboratory tests, namely, laboratory testing of materials; studying and conducting medical research projects, namely, conducting of feasibility studies in the field of new pharmaceutical technologies; engineering; provision and exchange of knowledge, industrial know-how and data information and consultation in the field of scientific research and development; providing technical expertise consultation and advice in the field of scientific research for medical purposes; piloting working groups bringing together scientists and industrial experts to solve health problems in the nature of consultation in the field of health risk assessment, namely, prediction and assessment of health risks to public and private agencies, facilities, individuals and locations following an accidental or terrorist caused release of chemical, biological, radiological or nuclear materials; design, development, scientific and medical research and engineering services in the field of medical devices; consultation with respect to the design and development of medical devices; scientific research, analysis and technical engineering assessment services of medical device design and development; services for the testing, and certification being testing, analysis and evaluation of the goods and services of others to determine conformity with certification standards and quality control of medical devices; providing temporary use of online non-downloadable computer aided design (CAD) software for designing medical devices.
Description of MarkThe mark consists of the stylized wording "BEAMS" with the design of a triangle with rounded sides to the left of the letter "B" in "BEAMS".

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 14, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBEAMS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Thursday, August 14, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 15, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 15, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, October 21, 2025ASSIGNED TO EXAMINER
Tuesday, October 28, 2025NON-FINAL ACTION WRITTEN
Wednesday, October 29, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, December 8, 2025REFUSAL PROCESSED BY MPU
Monday, December 8, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, December 25, 2025REFUSAL PROCESSED BY IB
Thursday, January 15, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 15, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 15, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 15, 2026SUSPENSION LETTER WRITTEN
Thursday, January 15, 2026LETTER OF SUSPENSION E-MAILED
Thursday, January 15, 2026NOTIFICATION OF LETTER OF SUSPENSION E-MAILED